According to the study, Cancer is proving the most fatal disease nowadays; therefor profiling cancer is in the great demand with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.
- Advertising -
The Global Cancer Tumor Profiling Market accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024.
The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.
No. of Report Pages: 350
Request for Free Sample of Global Cancer Tumor Profiling Market Visit @ databridgemarketresearch.com/reque…-profiling-market
Major Market Drivers and Restraints:
- Technological advancements for identifying the cancer tumors.
- Increasing the cancer incidences.
- Increase in the use of biomarkers in tumor profiling.
- Availability of Funding for Cancer Research
- Increase in demand for next generation sequencing technique in cancer profiling.
- Lack of Skilled Professionals and Infrastructure
- Growth in demand of personalized medicines
Browse Full Detailed with TOC, Sample, Inquiry, Expert and Global Cancer Tumor Profiling Market Visit @ databridgemarketresearch.com/repor…profiling-market/
By Technique the market is segmented in
By Application the market is segmented into
- Personalized Medicine
- Biomarker Discovery
- Research applications
On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as
- North America & South America
- Middle East & Africa
Top Key Players are:
tareIllumina, Inc., Qiagen N.V., F.
- Advertising -
Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.
For Any Query @ databridgemarketresearch.com/speak…-profiling-market
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: